【24h】

PROKR2 mutations in autosomal recessive Kallmann syndrome

机译:常染色体隐性Kallmann综合征的PROKR2突变

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To investigate the inheritance pattern of two missense PROKR2 changes within a single family. Design: This is a descriptive study. Setting: Tertiary referral center. Patient(s): The proband and his brother, both with congenital hypogonadotropic hypogonadism and anosmia (Kallmann syndrome). Intervention(s): Clinical and biochemical evaluation of Kallmann syndrome. Sequence analysis of the coding exons and exon-intron boundaries of KAL1, FGFR1, FGF8, PROK2, and PROKR2 from polymerase chain reaction (PCR)-amplified genomic DNA. Recombinant human FSH treatment of the proband. Main Outcome Measure(s): Phenotypic and genotypic features, and inhibin B response to recombinant human FSH. Result(s): The proband and his brother were homozygous for two variants in PROKR2; a novel mutation c.701G>A (p.G234D), and a polymorphism c.802C>T (p.R268C). Recombinant human FSH therapy of the proband increased serum inhibin B from <16 to 136 ng/L. The heterozygous parents were fertile and had six children. Conclusion(s): These findings are consistent with recessive mode of inheritance. PROKR2 signaling does not directly affect Sertoli cell function. ?2013 by American Society for Reproductive Medicine.
机译:目的:研究单个家族中两个错义PROKR2变异的遗传模式。设计:这是一个描述性研究。地点:第三级转诊中心。患者:先证者和他的兄弟,均患有先天性性腺功能低下性腺功能减退症和失眠症(Kallmann综合征)。干预措施:Kallmann综合征的临床和生化评估。聚合酶链反应(PCR)扩增的基因组DNA对KAL1,FGFR1,FGF8,PROK2和PROKR2的编码外显子和外显子内含子边界的序列分析。先证者的重组人FSH治疗。主要观察指标:表型和基因型特征,以及对重组人FSH的抑制素B反应。结果:先证者和他的兄弟是PROKR2中两个变异的纯合子。新突变c.701G> A(p.G234D),多态性c.802C> T(p.R268C)。先证者的重组人FSH治疗将血清抑制素B从<16 ng / L增加到136 ng / L。杂合子的父母肥沃,有六个孩子。结论:这些发现与隐性遗传方式一致。 PROKR2信号传导不会直接影响支持细胞功能。 ?2013年美国生殖医学学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号